Tirzepatide, like other GLP-1 and GIP receptor agonists, is associated with a predictable adverse effect profile that patients and clinicians should recognize
You do not want to be figuring out what to eat when you feel queasy
However, Mounjaro has a dual mechanism (GLP-1 and GIP receptor activation), which may amplify its effects on digestion compared to GLP-1-only medications like Ozempic and Wegovy
Diabetes Model Research Several rodent studies have explored Tirz in type 2 diabetes models, where it demonstrated improvements in glucose tolerance, HbA1c levels, and pancreatic beta-cell function
Just like with other GLP-1 (glucagon-like peptide-1) medications, the side effect seems to be dose-dependent, meaning it's more likely to occur at higher doses
When swallowing the remaining liquid after the sublingual hold, some users experience throat burning or irritation